Ghaziabad, India, April 30, 2019 — MilliporeSigma, a leading science and technology company, today announced the handover of a fully equipped microbiological testing laboratory to the Food Safety and Standards Authority of India (FSSAI). The Center for Microbiological Analysis Training (C-MAT) will provide training to food safety scientists from government laboratories and FSSAI-ratified private laboratories on the latest technology in microbiological testing.
“The importance of food safety in India has grown, given the increasing level of processing and overall food production,” said Udit Batra, Member of the Executive Board, Merck KGaA, Darmstadt, Germany CEO MilliporeSigma. “We will continue to provide skills training, implement new technologies for food testing to address quality requirements and advance food safety for India, as well as the global market.”
The MilliporeSigma-developed C-MAT is equipped with technology that will help solve many of the challenges faced by food safety scientists in pathogen testing and Hazard Analysis Critical Control Point (HACCP) Audit management. HACCP is an internationally accepted technique for preventing microbiological, chemical and physical contamination along the food supply chain. It identifies the risks, establishes critical control points, sets critical limits and ensures control measures are validated, verified and monitored before implementation. The laboratory is designed to meet the Biosafety Level-2 standard for microbial testing.
“I am very happy to note that MilliporeSigma is establishing the microbiological center at our National Food Laboratory in Ghaziabad,” said Pawan Agarwal, CEO, FSSAI. “This is going to be a world-class training center for food analysts and other technical staff from laboratories across the country.”
MilliporeSigma offers a complete food pathogen testing platform to the food and beverage safety testing market and is advancing global food and beverage safety and quality though lab testing efficiency and regulatory expertise.
Food Safety and Standards Authority of India is an autonomous body established under the Ministry of Health & Family Welfare, Government of India. The FSSAI has been established under the Food Safety and Standards Act, 2006 which is a consolidating statute related to food safety and regulation in India. FSSAI is responsible for protecting and promoting public health through the regulation and supervision of food safety.
About the Life Science Business of Merck KGaA, Darmstadt, Germany
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has some 22,000 employees and 59 manufacturing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services.
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and performance materials. Around 57,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene-editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2019, Merck KGaA, Darmstadt, Germany generated sales of €16.2 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck, KGaA, Darmstadt, Germany, visit www.emdgroup.com.
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.